Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia 1 Glioblastoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Fluorouracil 80 Oxaliplatin 72 Leucovorin 66 Irinotecan 60 Capecitabine 58 Bevacizumab 57 Cetuximab 43 Folfox protocol 22 Drug Therapy 22 Neoadjuvant Therapy 19 HMPL-013 17 Colonoscopy 17 regorafenib 15 apatinib 11 Panitumumab 11 Chemotherapy, Adjuvant 11 trifluridine tipiracil drug combination 10 XELOX 10 Laparoscopy 10 IFL protocol 10 sintilimab 9 raltitrexed 9 Radiotherapy 9 Blood Specimen Collection 9 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 tislelizumab 7 pembrolizumab 7 Endoscopic Mucosal Resection 7 Aspirin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × Antibodies, Monoclonal × Clear all

NCT06115174 2023-11-02

CRC - PTX

Tanta University

Phase 4 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡